Association of coagulation factor Ⅶ with the risk of myocardial infarction in the Chinese

( views:58, downloads:0 )
Author:
CAI Qiangjun()
Chen Jilin()
MA Huili()
SONG Jie()
XU Minilu()
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
Volume 113, Issue 12, 2000
DOI:
Key Word:
coagulation factor Ⅶ;gene polymorphism·triglyceride·myocardial infarction

Abstract: Objective To elucidate the association of plasma factor Ⅷ oagulant activity(FⅦc)with me risk of myocardial infarction (MI) and to assess the influence of factor Ⅶ gene Mspl polymorphism and lipid metabolism on FⅦc in the Chinese. Methods A total of 137 patients with angiographically confirmed MI and 125 healthy individuals were evaluated retrospectively. Plasma FⅦC was measured by one-stage prothrombin time,and FⅦ genotype was determined after Mspl digestion of polymerase chain reaction-amplified genomic DNA.Serum lipidlevels were assessed by routine methods.Results MI patients had significantly higher levels of FⅦc (119.5%±22.7% vs 99.9%±21.8%,P<0.01) and total serum cholesterol (5.80±1.06mmol/L vs 5.53±1.08 mmol/L, P<0.05) than controls, but only FⅦc independently correlated with the risk of MI (OR=1.04, P<0.01). There were no significant differences in FⅦ genotype or allele frequency between patients and controls (P>0.05).Subjects with the Gln353 allele were associated with significantly lower FⅦc levels than Arg353homozygotes (99.7%±19.3% vs 111.4%±24.6%,P<0.05). Serum triglyceride was positively correlated with plasma FⅦc in both control(r=0.25, P<0.01)and case (r=0.87, P<0.01) groups, but this correlation was restricted to Arg/Arg genotypa (r=0.68, P<0.01).A significant correlation of total serum cholesterol with FⅦc only appeared in Arg/Arg homozygotes (r=0.17, P<0.01). Conclusions Our findings support the role of plasma FⅦc as a risk factor for MI in Chinese. Plasma triglyceride and FⅦ gene Mspl pclymorphism are two independent determinants of FⅦc. Assay of this polymorphism will be helpful in determining who will benefit most from lipid-lowing therapy.

  • 1. Meade TW, Mellows S, Brwovic M, et al. Haemostatic function and ischemia heart disease:principal results of the Northwick Park Heart Study Lancet 1986;2:533-537.
  • 2.Green F, Kelleher C, Wilkes H, et al. A common genetic polymorphism associated with lower coagulation factor Ⅶ levels in healthy indialduals. Arterioscler Thromb 1991; 11:540-546.
  • 3.Junker R,Heinrich J,Schulte H,et al.Coagulation factor V Ⅶ and the risk of coronary heart disease in healthy men.Arterioscler Thromb Vasc Biol 1997;17:1539-1544.
  • 4.The Medical Research Council’s General Practice Research Framework.Thrombosis prevention trial:randomised trial of lowintensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk.Lancet 1998;351:233-241.
  • 5.Iacoviello L,Di Castelnuovo A,De Knijff P,et al.Polymorphisms in the coagulation factor Ⅶ gene and the risk of myocardial infarction.N Engl J Med 1998;338:79-85.
  • 6.Pankow JS,Folsom AR,Shahar E,et al.Weight-loss induced changes in plasma factor Ⅶ coagulant activity and relation to the factor Ⅶ Arg/Gln353 polymorphism in moderately obese adults.Thromb Haemost 1998;79:784-789
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn